New York – September 28, 2026 -- Lazard, Inc. (NYSE: LAZ) has appointed Pranjal Gambhir as Head of Medical Technology, based in New York, as the advisory firm expands its healthcare coverage.
Gambhir brings two decades of Citi experience to Lazard's healthcare practice
Gambhir joins from Citi, where he most recently served as Managing Director covering Medical Technology companies across multiple sub-sectors. He spent 20 years at Citi in roles based in New York and New Delhi, building coverage across the sector's various segments.
Lazard positions the hire as deepening strategic advisory capacity for Medical Technology clients
David Gluckman, Global Head of Healthcare at Lazard, said Gambhir's broad experience across Medical Technology sub-sectors adds strategic depth to the firm's Healthcare Group as it continues to grow. In his new role, Gambhir will lead coverage of Medical Technology companies, advising clients on strategy and corporate development transactions across the sector.
Gambhir cites sector complexity as driving demand for independent advisory work
Gambhir said the Medical Technology sector continues to evolve rapidly, creating both opportunity and complexity for clients, and pointed to Lazard's independent perspective and global platform as tools leadership teams, boards and investors need to navigate the shifting landscape.
Gambhir holds an MBA from the Indian School of Business and a Bachelor of Commerce from Delhi University.